Evgen Pharma

(1:39)

EVGEN PHARMA PLC - Post AGM Presentation

(33:13)

Evgen Pharma CMO highlights \

(7:9)

Evgen Pharma \

(7:18)

EVGEN PHARMA PLC - Investor Presentation

(23:36)

EVGEN PHARMA PLC - Post-AGM Q\u0026A

(35:34)

Evgen Pharma ready to prove broccoli drug's worth

(7:45)

Evgen Pharma presents at the Proactive One2One Investor Forum - March 23rd 2023

(30:6)

Revolutionizing Pharma Cold Chain through Envirotainer’s Strategy

(11:41)

Interview with experts in pharmacokinetics and pharmacodynamics

(1:37:43)

'Starving away' cancer: One of our reporters tried it

(3:47)

Evgeny Khmara - Element

(3:57)

The Future of Pharma with Jeremy Levin

(36:5)

The Transforming Health Series: Where market access meets patient access

(24:28)

THERACRYF PLC - Half Year Results

(29:7)

Designing Your Career as a Regulatory Professional

(29:15)

4D pharma updates on their phase II study of Blautix for the treatment of Irritable Bowel Syndrome

(6:29)

Assurance maladie : peut-on encore innover ? Avec Marguerite Cazeneuve

(1:8:9)

EVGEN PHARMA PLC - Investor Presentation

(30:42)

EVGEN PHARMA PLC - Interim Results 2022-23

(29:)

Evgen Pharma signs partnership deal with Stalicla for autism treatment research

(6:10)

Evgen Pharma talks through clinical milestones and financial results from its 2022 full year report

(6:9)

Riccardo Lowi discusses Evgen Pharma

(4:18)

Evgen Pharma have 'many shots at goal', solving unmet needs in the pharmaceutical industry

(7:28)

EVGEN PHARMA PLC BIG TRADING JUMP | EVGEN PHARMA PLC SHARE

(2:31)

Evgen Pharma presents 2022 clinical trials plans and progress with US and UK regulators

(6:24)

Evgen Pharma \

(8:49)

EVGEN PHARMA PLC - Preliminary pharmacokinetic results from Phase 1b study of new SFX-01 tablet for

(17:48)

Evgen portfolio update on core field of cancer, 'the R\u0026D is entirely on plan and on budget'

(9:54)